As in vitro experiments confirmed that monobenzone inhibited KDM1A enzyme activity effectively, and KDM1A plays as a contributor in the migration of gastric cancer (Pan et al., 2019; Zhang et al., 2019), we assessed the effects of monobenzone on the migration ability of gastric cancer cells. The gene discussed is KDM1A; the disease is gastric cancer.